ImmuPharma PLC (IMM) — Capital Reinvestment Ratio

Latest as of December 2009: 0.00x

ImmuPharma PLC (IMM) has a Capital Reinvestment Ratio of 0.00x as of December 2009, meaning it reinvests 0% of its operating cash flow (GBX11.96 Million) in capital expenditures (GBX3.60K). See IMM equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

GBX11.96 Million
GBX

Capital Expenditures

GBX3.60K
GBX

Data as of

Dec 2009
Most recent filing

ImmuPharma PLC Capital Reinvestment Ratio (2009–2009)

This chart tracks ImmuPharma PLC's Capital Reinvestment Ratio across 1 annual periods. Check IMM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for ImmuPharma PLC (2009–2009)

Year-by-year Capital Reinvestment Ratio for ImmuPharma PLC from 2009 to 2009. For live market cap and broader valuation context, see ImmuPharma PLC stock valuation.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
2009 0.00x GBX11.96 Million GBX4.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow